PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25852275-8 2015 CONCLUSION: In response-guided Peg-IFNalpha/RBV combination therapy for chronically HCV G2-infected patients, the impact of the IFNL3 genotype on SVR was limited to non-RVR patients. peg-ifnalpha 31-43 interferon lambda 3 Homo sapiens 128-133 27156332-0 2016 Correlation Study Between IL-28B Gene Polymorphism (rs8099917SNP) and Sustained Virological Response in Iranian Patients with Chronic Hepatitis C. BACKGROUND: The current standard treatment for hepatitis C is a combination of pegylated interferon alpha and ribavirin (peg-IFNalpha/RBV). peg-ifnalpha 268-280 interferon lambda 3 Homo sapiens 26-32 23314745-3 2013 We determined three SNPs of IL-28B (rs12979860, rs12980275, and rs8099917) in 82 patients with chronic HCV infection treated with pegylated interferon alpha and ribavirin (peg-IFNalpha/RBV). peg-ifnalpha 172-184 interferon lambda 3 Homo sapiens 28-34